PsA Primary Efficacy Results

ACR=American College of Rheumatology; BID=twice daily; csDMARD=conventional synthetic disease-modifying antirheumatic drug; DMARD=disease-modifying antirheumatic drug; HAQ-DI=Health Assessment Questionnaire-Disability Index; IR=inadequate responder; JAK=Janus kinase; PsA=psoriatic arthritis; q 2 wk=every 2 weeks; SC=subcutaneously; TNFi=tumor necrosis factor inhibitor.